Advertisement
Advertisement
March 18, 2015
Commercialization Agreement Announced for Forge Medical's VasoStat Hemostasis Device
March 19, 2015—Forge Medical, Inc., manufacturer of the VasoStat hemostasis device announced that the company had entered into a national commercialization agreement for the device with National Medical Sales LLC, a United States distributor of interventional and vascular specialty products. The VasoStat is used for radial artery and dialysis access hemostasis.
Timothy W.I. Clark, MD, who is cofounder and CEO of Forge Medical, commented, “With the growing utilization of transradial access for coronary and peripheral vascular procedures, clinicians demand an effective solution for puncture-site management with patent hemostasis. With the increasing data supporting the safety and superiority of transradial access over traditional transfemoral access, we are proud to provide a unique and innovative hemostasis device to meet this need.”
Dr. Clark is Associate Professor of Clinical Radiology at the University of Pennsylvania Perelman School of Medicine, Division of Interventional Radiology, Department of Radiology, and is the Director of Interventional Radiology at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania.
Advertisement
Advertisement
